anmelden
OMX Nordic 40
2.715,53
PKT
-2,53
PKT
-0,09
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.09.22 | Kone Sell | Goldman Sachs Group Inc. | |
| 08.09.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 07.09.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 07.09.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 06.09.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.09.22 | Hennes Mauritz (H M, H&M) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.22 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 02.09.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 02.09.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.09.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 01.09.22 | Kone Buy | UBS AG | |
| 01.09.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.09.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.09.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 26.08.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 26.08.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 26.08.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 25.08.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 25.08.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
| 23.08.22 | Novo Nordisk Sell | UBS AG | |
| 22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.08.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 18.08.22 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 17.08.22 | Novo Nordisk Sell | UBS AG | |
| 15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
| 09.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.08.22 | Kone Sector Perform | RBC Capital Markets | |
| 05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.08.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.08.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
| 04.08.22 | AstraZeneca Overweight | Barclays Capital | |
| 04.08.22 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 02.08.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. |
